Venclexta (venetoclax tablets) — Cigna
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma
Initial criteria
- Patient is age ≥ 18 years; AND
- Patient has tried at least one systemic regimen.
Approval duration
1 year
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma
1 year